PCOS with Hirsutism or Androgen-Related Alopecia When Combined Oral Contraceptives Are Contraindicated or Not Tolerated

This protocol addresses polycystic ovarian syndrome presenting with hirsutism and/or androgen-related alopecia in patients for whom combined oral contraceptive pills (COCPs) are contraindicated or poorly tolerated — provided that another effective form of contraception is in place.

When COCPs cannot be used, an alternative hormonal strategy targeting androgen activity is considered to address hirsutism and androgen-related hair loss. The full regimen — including agent selection and management details — is detailed in the structured protocol.